Nebenwirkungen · Edistride
Edistride 5 mg film-coated tablets Edistride 10 mg film-coated tablets · Abschnitt 4.8 · PDF-Seite 11
HOS-224532 · Präparat HOS-217316
In an add-on to insulin study, episodes of major hypoglycaemia were reported in 0.5% and 1.0% of subjects treated with dapagliflozin 10 mg plus insulin at weeks 24 and 104, respectively, and in 0.5% of subjects treated with placebo plus insulin groups at weeks 24 and 104. At weeks 24 and 104, minor episodes of hypoglycaemia were reported, respectively, in 40.3% and 53.1% of subjects who received dapagliflozin 10 mg plus insulin and in 34.0% and 41.6% of the subjects who received placebo plus insulin.
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2026-03-13T12:41:00Z · SHA-256 92789e5793f52d82c6a79fccb3dfa96c323039b61574cebf416504cd86fe6891 · Passage a979cc624a796f7ac9949947efafd2b223470f33e9fd5fd2dea8860fab8d2ad7 · Zeichen 11954–12459 im Abschnitt